Navigation Links
Masimo Launches First Non-adhesive Pulse Oximetry Sensor Designed For Extremely Low Birth Weight Babies
Date:11/5/2008

dren's Hospital in Loma Linda, CA, stated; "The new LNCS(R) SofTouch NeoPt-500 sensor solves the problems associated with typical pulse oximetry sensors in ELBW infants. ELBW neonates are much more susceptible to skin burn injury and full thickness ulcer formations caused by improper sensor design and placement. Skin injury compromises the body's most basic protection mechanism and, in this most vulnerable population, the problems and risks associated with sensors not designed or intended for ELBW newborns have much greater consequences. Masimo is a unique company that not only understands this, but designs and develops clinically-relevant solutions to overcome these challenges."

Masimo SofTouch sensors are designed for single-patient use whenever skin sensitivity is a concern. SofTouch sensors incorporate a hook and loop wrap -- allowing the sensor to be quickly and securely applied on wet and slippery sites, and easily repositioned if necessary. Newborn skin is further protected by soft foam material that surrounds the sensor attachment for maximum comfort, and the NeoPt-500 contains no adhesive materials exposed to skin contact areas. This prevents epidermal stripping and skin trauma typically caused by applying and repositioning an adhesive sensor.

Joe E. Kiani, Founder and CEO of Masimo, stated; "The new LNCS SofTouch NeoPt-500 sensor underscores our core philosophy of 'doing what is best for patient care.' We believe that every patient deserves appropriate monitoring solutions. That's why Masimo provides over 100 different sensors, each uniquely designed to deliver the performance and measurement clinicians want -- including 15 different sensor options to address the challenging needs and specific requirements of neonatal patients."

About Masimo

Masimo (NASDAQ:

SOURCE Masimo
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Masimo Reports Second Quarter 2008 Financial Results
2. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With Remarkable Results
4. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
5. Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
6. Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry
7. Masimo to Report First Quarter 2008 Financial Results on April 29, 2008
8. Masimo to Report Fourth Quarter and Fiscal Year 2007 Financial Results on February 26, 2008
9. The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology
10. Masimo Celebrates 500,000th Pulse Oximeter Shipped
11. Masimo to Present at 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... CO (PRWEB) November 22, 2014 ... growth equity investments in the consumer brand sector, ... The investment will be used to help fund ... product pipeline rollout, particularly its proprietary apparel and ... will join BackJoy’s Board of Directors. , BackJoy ...
(Date:11/22/2014)... A Xarelto lawsuit has been filed on behalf of ... in damages from the makers and marketers of the ... woman began using Xarelto in March 2012 and used it ... suffered life-threatening bleeding in July 2012 and as a result, ... distress. The lawsuit purports that the woman’s injuries are due ...
(Date:11/22/2014)... Nov. 21, 2014 (HealthDay News) -- The widely used ... death and hospitalization among patients who have the heart ... failure, a new study finds. Atrial fibrillation is ... linked to a rise in risk for stroke among ... a century to help treat irregular heartbeat, the authors ...
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- Seeking to make ... U.S. Food and Drug Administration on Thursday approved a ... Hydrocodone -- best known by the brand name ... been tied to a surge in dangerous addictions across ... approved Hysingla ER (hydrocodone bitartrate) is an extended-release tablet ...
(Date:11/21/2014)... MLF Biotech, Inc. has developed a ... Probiotics for Pets helps maintain digestive health and can ... intestinal flora after it experiences a period of stress, ... for Pets is a proprietary blend of pure probiotics ... active bacteria strains that are safe and effective for ...
Breaking Medicine News(10 mins):Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2
... , BIRMINGHAM, Ala., Aug. 19 ... more individuals, organizations, and society will continue to ... and communication technology or (ICT). With an ever-expanding ... GASICORP, worldwide leader in information and communication technology, ...
... CHICAGO, Aug. 19 As Electronic Health Record (EHR) Solution Providers race ... e ntric, Inc , offers practical advice for evaluating and designing ... We b i nars will highlight techniques used ... clinician performance while increasing adoption. , , Measuring and improving ...
... NEW YORK, Aug. 19 Bayard Advertising Agency, Inc., ... clients in a broad array of industries, announces its selection ... (HCA) West Florida Division. , , ... notes Jennifer Berres, VP Human Resources for HCA West Florida ...
... ... have a healthier lifestyle by health experts from Avon Obesity Service. , ... (PRWEB) August 19, 2009 -- A smoking alternative has been suggested ... ,Patients have been introduced to the Intellicig electronic cigarettes at Avon Obesity ...
... Biotech Ltd.,(NYSE Amex: SVA ), a leading developer and provider ... and six-,month periods ended June 30, 2009. , , ... to $20.0 million, -- Sales for the six-month period ... the quarter rose 52% to $10.7 million, -- Operating ...
... responsible for more than two thirds of the total ... newly adapted low-dose technique called adaptive statistical iterative reconstruction ... from CT up to 65 percent, according to a ... American Journal of Roentgenology (AJR). Iterative ...
Cached Medicine News:Health News:Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 2Health News:Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 3Health News:User Centric to Present Health IT Usability Webinar Series 2Health News:Bayard Advertising Appointed by Hospital Corporation of America (HCA) West Florida Division for Recruitment Advertising and Employment Branding 2Health News:Health Experts Praise Intellicig Electronic Cigarette 2Health News:Health Experts Praise Intellicig Electronic Cigarette 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 2Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 4Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 5Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 6Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 7Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 8Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 9Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 10Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 11Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 12Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 13Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 14
(Date:11/22/2014)... 2014 Research and Markets  has announced the ... Report, 2014-2017" report to their offering. ... recombinant protein drug market has been expanding rapidly owing ... the like. During 2005-2013, sales of recombinant protein drugs ... of 19.1%, and it is projected that ...
(Date:11/21/2014)... SAN DIEGO , Nov. 21, 2014 /PRNewswire/ ... TNDM ), a medical device company and ... today announced a partnership with Tidepool, a non-profit ... an open source software platform that increases diabetes ... the Tidepool Platform, which is currently under development, ...
(Date:11/21/2014)... , Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care instruments and consumables for the medical, research, and ... the veterinary and research markets in the ... a stock purchase agreement to acquire 100% of QCR ... based distribution organization. The transaction closed on ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... Inc.,(NYSE:MDT) today announced that a review of ... that the trial has met its primary,non-inferiority ... a randomized, single-blind,trial evaluating the safety and ... as compared to the TAXUS Paclitaxel-Eluting,Coronary Stent ...
... Cardiovascular Target from Lexicon's Genetic,Research -, ... /PRNewswire-FirstCall/ --,Lexicon Pharmaceuticals, Inc. today reported ... directed to a,potential new target, angiopoietin-like ... cholesterol. Research suggests that,a monoclonal antibody ...
Cached Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
... System facilitates the placement ... to cross and recanalize ... Safe-Cross system is a ... Coherence Reflectometry (OCR) Forward-looking ...
... patients and visitors is crucial for ... environment. Achieve this and more with ... patient and visitor identification system, fit ... can be used stand-alone, networked, or ...
Medicine Products: